Literature DB >> 24491487

A novel missense mutation in POMT1 modulates the severe congenital muscular dystrophy phenotype associated with POMT1 nonsense mutations.

Stephanie E Wallace1, Jessie H Conta2, Thomas L Winder3, Tobias Willer4, Jamie M Eskuri5, Richard Haas6, Kathleen Patterson7, Kevin P Campbell8, Steven A Moore9, Sidney M Gospe10.   

Abstract

Mutations in POMT1 lead to a group of neuromuscular conditions ranging in severity from Walker-Warburg syndrome to limb girdle muscular dystrophy. We report two male siblings, ages 19 and 14, and an unrelated 6-year old female with early onset muscular dystrophy and intellectual disability with minimal structural brain anomalies and no ocular abnormalities. Compound heterozygous mutations in POMT1 were identified including a previously reported nonsense mutation (c.2167dupG; p.Asp723Glyfs*8) associated with Walker-Warburg syndrome and a novel missense mutation in a highly conserved region of the protein O-mannosyltransferase 1 protein (c.1958C>T; p.Pro653Leu). This novel variant reduces the phenotypic severity compared to patients with homozygous c.2167dupG mutations or compound heterozygous patients with a c.2167dupG mutation and a wide range of other mutant POMT1 alleles.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital muscular dystrophy; Dystroglycanopathy; Limb girdle muscular dystrophy; POMT1; Protein O-mannosylation; Walker–Warburg syndrome

Mesh:

Substances:

Year:  2014        PMID: 24491487      PMCID: PMC3959257          DOI: 10.1016/j.nmd.2014.01.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  43 in total

1.  Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm.

Authors:  Prateek Kumar; Steven Henikoff; Pauline C Ng
Journal:  Nat Protoc       Date:  2009-06-25       Impact factor: 13.491

2.  Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin alpha2 deficiency and abnormal glycosylation of alpha-dystroglycan.

Authors:  M Brockington; D J Blake; P Prandini; S C Brown; S Torelli; M A Benson; C P Ponting; B Estournet; N B Romero; E Mercuri; T Voit; C A Sewry; P Guicheney; F Muntoni
Journal:  Am J Hum Genet       Date:  2001-10-08       Impact factor: 11.025

3.  Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1.

Authors:  A Yoshida; K Kobayashi; H Manya; K Taniguchi; H Kano; M Mizuno; T Inazu; H Mitsuhashi; S Takahashi; M Takeuchi; R Herrmann; V Straub; B Talim; T Voit; H Topaloglu; T Toda; T Endo
Journal:  Dev Cell       Date:  2001-11       Impact factor: 12.270

Review 4.  Dystroglycanopathies: coming into focus.

Authors:  Caroline Godfrey; A Reghan Foley; Emma Clement; Francesco Muntoni
Journal:  Curr Opin Genet Dev       Date:  2011-03-11       Impact factor: 5.578

Review 5.  Update on the genetics of limb girdle muscular dystrophy.

Authors:  Satomi Mitsuhashi; Peter B Kang
Journal:  Semin Pediatr Neurol       Date:  2012-12       Impact factor: 1.636

6.  A method and server for predicting damaging missense mutations.

Authors:  Ivan A Adzhubei; Steffen Schmidt; Leonid Peshkin; Vasily E Ramensky; Anna Gerasimova; Peer Bork; Alexey S Kondrashov; Shamil R Sunyaev
Journal:  Nat Methods       Date:  2010-04       Impact factor: 28.547

7.  Post-translational disruption of dystroglycan-ligand interactions in congenital muscular dystrophies.

Authors:  Daniel E Michele; Rita Barresi; Motoi Kanagawa; Fumiaki Saito; Ronald D Cohn; Jakob S Satz; James Dollar; Ichizo Nishino; Richard I Kelley; Hannu Somer; Volker Straub; Katherine D Mathews; Steven A Moore; Kevin P Campbell
Journal:  Nature       Date:  2002-07-25       Impact factor: 49.962

8.  Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.

Authors:  Dirk J Lefeber; Johannes Schönberger; Eva Morava; Mailys Guillard; Karin M Huyben; Kiek Verrijp; Olga Grafakou; Athanasios Evangeliou; Frank W Preijers; Panagiota Manta; Jef Yildiz; Stephanie Grünewald; Martha Spilioti; Christa van den Elzen; Dominique Klein; Daniel Hess; Hisashi Ashida; Jan Hofsteenge; Yusuke Maeda; Lambert van den Heuvel; Martin Lammens; Ludwig Lehle; Ron A Wevers
Journal:  Am J Hum Genet       Date:  2009-07-02       Impact factor: 11.025

9.  Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies.

Authors:  M Lommel; S Cirak; T Willer; R Hermann; G Uyanik; H van Bokhoven; C Körner; T Voit; I Barić; U Hehr; S Strahl
Journal:  Neurology       Date:  2010-01-12       Impact factor: 9.910

10.  Ethnically diverse causes of Walker-Warburg syndrome (WWS): FCMD mutations are a more common cause of WWS outside of the Middle East.

Authors:  M Chiara Manzini; Danielle Gleason; Bernard S Chang; R Sean Hill; Brenda J Barry; Jennifer N Partlow; Annapurna Poduri; Sophie Currier; Patricia Galvin-Parton; Lawrence R Shapiro; Karen Schmidt; Jessica G Davis; Lina Basel-Vanagaite; Mohamed Z Seidahmed; Mustafa A M Salih; William B Dobyns; Christopher A Walsh
Journal:  Hum Mutat       Date:  2008-11       Impact factor: 4.878

View more
  8 in total

Review 1.  Cystic kidneys in fetal Walker-Warburg syndrome with POMT2 mutation: Intrafamilial phenotypic variability in four siblings and review of literature.

Authors:  Marwa M Nabhan; Nour ElKhateeb; Daniela A Braun; Sungho Eun; Sahar N Saleem; Heon YungGee; Friedhelm Hildebrandt; Neveen A Soliman
Journal:  Am J Med Genet A       Date:  2017-08-17       Impact factor: 2.802

2.  Analysis of phenotype, enzyme activity and genotype of Chinese patients with POMT1 mutation.

Authors:  Haipo Yang; Hiroshi Manya; Kazuhiro Kobayashi; Hui Jiao; Xiaona Fu; Jiangxi Xiao; Xiaoqing Li; Jingmin Wang; Yuwu Jiang; Tatsushi Toda; Tamao Endo; Xiru Wu; Hui Xiong
Journal:  J Hum Genet       Date:  2016-05-19       Impact factor: 3.172

Review 3.  What Have We Learned from Glycosyltransferase Knockouts in Mice?

Authors:  Pamela Stanley
Journal:  J Mol Biol       Date:  2016-03-31       Impact factor: 5.469

Review 4.  Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview.

Authors:  Malihe Mohamadian; Mandana Rastegar; Negin Pasamanesh; Ata Ghadiri; Pegah Ghandil; Mohsen Naseri
Journal:  J Mol Neurosci       Date:  2021-11-02       Impact factor: 3.444

5.  Compound heterozygous POMT1 mutations in a Chinese family with autosomal recessive muscular dystrophy-dystroglycanopathy C1.

Authors:  Pengzhi Hu; Song Wu; Lamei Yuan; Qiongfen Lin; Wen Zheng; Hong Xia; Hongbo Xu; Liping Guan; Hao Deng
Journal:  J Cell Mol Med       Date:  2017-02-03       Impact factor: 5.310

6.  Detection of variants in dystroglycanopathy-associated genes through the application of targeted whole-exome sequencing analysis to a large cohort of patients with unexplained limb-girdle muscle weakness.

Authors:  Katherine Johnson; Marta Bertoli; Lauren Phillips; Ana Töpf; Peter Van den Bergh; John Vissing; Nanna Witting; Shahriar Nafissi; Shirin Jamal-Omidi; Anna Łusakowska; Anna Kostera-Pruszczyk; Anna Potulska-Chromik; Nicolas Deconinck; Carina Wallgren-Pettersson; Sonja Strang-Karlsson; Jaume Colomer; Kristl G Claeys; Willem De Ridder; Jonathan Baets; Maja von der Hagen; Roberto Fernández-Torrón; Miren Zulaica Ijurco; Juan Bautista Espinal Valencia; Andreas Hahn; Hacer Durmus; Tracey Willis; Liwen Xu; Elise Valkanas; Thomas E Mullen; Monkol Lek; Daniel G MacArthur; Volker Straub
Journal:  Skelet Muscle       Date:  2018-07-30       Impact factor: 4.912

7.  Childhood onset limb-girdle muscular dystrophies in the Aegean part of Turkey.

Authors:  Uluç Yiş; Gülden Diniz; Filiz Hazan; Hülya Sevcan Daimagüler; Bahar Toklu Baysal; Figen Baydan; Gülçin Akinci; Aycan Ünalp; Gül Aktan; Erhan Bayram; Semra Hiz; Cem Paketçi; Derya Okur; Erdener Özer; Ayça Ersen Danyeli; Muzaffer Polat; Gökhan Uyanik; Sebahattin Çirak
Journal:  Acta Myol       Date:  2018-09-01

8.  Clinical long-time course, novel mutations and genotype-phenotype correlation in a cohort of 27 families with POMT1-related disorders.

Authors:  Tobias Geis; Tanja Rödl; Haluk Topaloğlu; Burcu Balci-Hayta; Sophie Hinreiner; Wolfgang Müller-Felber; Benedikt Schoser; Yasmin Mehraein; Angela Hübner; Birgit Zirn; Markus Hoopmann; Heiko Reutter; David Mowat; Gerhard Schuierer; Ulrike Schara; Ute Hehr; Heike Kölbel
Journal:  Orphanet J Rare Dis       Date:  2019-07-16       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.